Stocks and Investing
Stocks and Investing
Wed, May 8, 2024
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
[ Wed, May 08th 2024
] - WOPRAI
Danielle Antalffy Maintained (TMCI) at Strong Buy with Decreased Target to $16 on, May 8th, 2024
Danielle Antalffy of UBS, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $17 to $16 on, May 8th, 2024.
Danielle, nor any peers, have made any analyst calls on TMCI in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources